3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
7
Prostatic Neoplasms
6
Brain Neoplasms
6
Neoplasm Metastasis
5
Breast Neoplasms
4
Pancreatic Neoplasms
3
Lung Neoplasms
3
Melanoma
2
Carcinoma, Renal Cell
2
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Spinal Cord Diseases
1
Spinal Cord Compression
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Prostate Cancer Metastatic Disease
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Mouth Neoplasms
1
Lymphatic Metastasis
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Epidural Neoplasms
1
Interventions
pembrolizumab
9
Cetuximab
5
Surveys and Questionnaires
4
Cisplatin
4
dostarlimab
2
abemaciclib
2
Standard of Care
2
Docetaxel
2
Carboplatin
2
130-nm albumin-bound paclitaxel
2
ulixertinib
1
trastuzumab deruxtecan
1
toripalimab
1
tislelizumab
1
tipifarnib
1
ribociclib
1
repotrectinib
1
patritumab deruxtecan
1
palbociclib
1
olaparib
1
nimotuzumab
1
monalizumab
1
ibrutinib
1
fludarabine
1
exemestane
1
entrectinib
1
ebselen
1
durvalumab
1
disitamab vedotin
1
avelumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Radiosurgery
×
30 days
×
Clear all
No trials found.